NAVIDEA BIOPHARMACEUTICALS, INC.·4

Mar 18, 11:10 AM ET

Tulip Thomas H. 4

4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Mar 18, 2013

Insider Transaction Report

Form 4
Period: 2013-03-15
Transactions
  • Purchase

    Common Stock

    2013-03-15$2.82/sh+17,500$49,35045,000 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    940
Footnotes (1)
  • [F1]Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $2.81 - $2.89. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.

Documents

1 file
  • 4
    v338474_4.xmlPrimary

    OWNERSHIP DOCUMENT